KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 84 filers reported holding KRONOS BIO INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $22,053 | -5.2% | 17,785 | -0.6% | 0.00% | – |
| Q1 2024 | $23,264 | -5.3% | 17,895 | -8.9% | 0.00% | – |
| Q4 2023 | $24,554 | -31.1% | 19,643 | -28.3% | 0.00% | – |
| Q3 2023 | $35,636 | -40.5% | 27,412 | -21.3% | 0.00% | – |
| Q2 2023 | $59,899 | -79.2% | 34,825 | -82.3% | 0.00% | – |
| Q1 2023 | $287,576 | -11.9% | 196,970 | -2.2% | 0.00% | – |
| Q4 2022 | $326,307 | +35995.9% | 201,424 | -25.3% | 0.00% | – |
| Q3 2022 | $904 | -40.4% | 269,785 | -35.3% | 0.00% | – |
| Q2 2022 | $1,518 | -99.9% | 417,242 | +98.9% | 0.00% | – |
| Q1 2022 | $1,517,000 | -33.0% | 209,825 | +26.0% | 0.00% | – |
| Q4 2021 | $2,264,000 | -7.3% | 166,560 | +43.0% | 0.00% | -100.0% |
| Q3 2021 | $2,441,000 | +262.2% | 116,489 | +313.6% | 0.00% | – |
| Q2 2021 | $674,000 | +24.6% | 28,164 | +52.4% | 0.00% | – |
| Q1 2021 | $541,000 | -57.4% | 18,480 | -56.5% | 0.00% | – |
| Q4 2020 | $1,270,000 | – | 42,531 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,765,314 | $3,428,989 | 3.75% |
| Wildcat Capital Management, LLC | 1,297,959 | $1,609,469 | 0.39% |
| Acuitas Investments, LLC | 443,457 | $549,887 | 0.29% |
| CM Management, LLC | 135,000 | $167,400 | 0.15% |
| Privium Fund Management (UK) Ltd | 292,182 | $341,853 | 0.13% |
| Alphabet Inc. | 1,438,232 | $1,783,408 | 0.09% |
| Forefront Analytics, LLC | 134,998 | $167,400 | 0.08% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 1,665,797 | $2,044,488 | 0.04% |
| Artal Group S.A. | 842,954 | $1,045,263 | 0.03% |
| VESTIA PERSONAL WEALTH ADVISORS | 15,718 | $19,490 | 0.02% |